You are here: Industry Insights > Cervical Cancer

News List

New government plan to speed up elimination of cervical cancer www.gov.cn
February 08, 2023
The central government has outlined a long-term plan to accelerate the elimination of cervical cancer by 2030 via an initiative aimed at boosting vaccination rates among girls.
Cemiplimab Prolongs Survival in Recurrent Cervical Cancer drugs.com
February 10, 2022
For patients with recurrent cervical cancer after first-line platinum-containing chemotherapy, survival is significantly longer with cemiplimab....
New NCCN Guidelines help Patients Better Understand and Participate in the Care of their Cervical Cancer prnasia
December 14, 2021
The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Cervical Cancer to help people with cervical cancer become more informed...
HPV Vaccine Is Reducing Cervical Cancers in Teens, Young Women Drugs
December 01, 2021
The first wave of girls to receive the HPV vaccine are much less likely to contract or die from cervical cancer than women just a few years older, a new study reports.
Could a Single Dose of the HPV Vaccine Be Enough? Drugs
November 29, 2021
Women getting vaccinated against the cancer-causing human papillomavirus (HPV) now need two or three shots, but an African clinical trial suggests a single dose is just as effective.
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA prnasia
September 28, 2021
Akeso, Inc. (the Company, 9926.HK) announces that the National Medical Products Administration (the NMPA) of China has officially accepted the new drug application for the world's first-in-class Cadonilimab...
Gap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by Enough drugs
July 05, 2021
Racial disparities in breast cancer survival have narrowed in recent years, but Black women with the disease still have double the death rate of white women.
Women's Cancer Screenings Plummeted During Pandemic drugs
July 01, 2021
Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention says.
Agenus BLA for Balstilimab as Treatment for Cervical Cancer Granted Priority Review by U.S. FDA americanpharmaceuticalreview
June 18, 2021
Agenus Inc., an immuno-oncology company with an extensive pipeline of agents including checkpoint antibodies, cell therapies, adjuvants, and vaccines that activate immune response to cancers and infections announced that the U.S. FDA accepted Agenus’ ...
ASCO: Incidence of Cervical Cancer Has Decreased in the United States drugs
June 02, 2021
The incidence of cervical cancer has decreased, while the incidence of other human papillomavirus (HPV), according to a study scheduled to be presented at the annual meeting of the American Society of of Clinical Oncology, held virtually from June 4 to 8.

Previous page 1 2 3 4 Next page